▁Introduction 7.8203125
: 1.90625
<0x0A> 6.52734375
Chr 7.55859375
onic 1.84375
▁infl 3.93359375
amm 0.80517578125
ation 0.01032257080078125
▁is 0.83447265625
▁a 0.8935546875
▁major 2.126953125
▁concern 5.140625
▁in 0.5322265625
▁individuals 6.90625
▁with 0.496826171875
▁end 5.60546875
- 0.39794921875
stage 0.006679534912109375
▁ren 0.220947265625
al 5.8531761169433594e-05
▁disease 0.028961181640625
▁( 0.458984375
ES 0.0079498291015625
R 0.0025234222412109375
D 6.413459777832031e-05
) 0.77294921875
▁under 2.876953125
going 0.0207366943359375
▁d 1.546875
ial 1.1086463928222656e-05
ysis 0.00537872314453125
. 0.77783203125
▁The 2.24609375
▁article 9.828125
▁" 3.865234375
Chr 2.3125
onic 0.00102996826171875
▁In 0.7060546875
fl 0.0100555419921875
amm 0.0628662109375
ation 0.0010471343994140625
▁in 0.9169921875
▁End 1.2138671875
- 0.0811767578125
Stage 0.1678466796875
▁Ren 0.04345703125
al 2.9206275939941406e-05
▁D 0.02215576171875
ise 0.0010080337524414062
ase 0.0031585693359375
▁and 3.310546875
▁D 1.349609375
ial 0.0017032623291015625
ysis 0.005458831787109375
" 0.57275390625
▁del 7.1484375
ves 0.4423828125
▁into 0.037841796875
▁the 0.16845703125
▁leading 7.54296875
▁causes 0.297119140625
▁of 0.2227783203125
▁chron 0.4970703125
ic 0.00013840198516845703
▁infl 0.01032257080078125
amm 0.01036834716796875
ation 0.0002772808074951172
▁in 0.193359375
▁individuals 2.189453125
▁with 0.08245849609375
▁E 0.01143646240234375
SR 0.0005288124084472656
D 9.059906005859375e-06
, 1.34765625
▁discuss 5.07421875
es 0.65771484375
▁the 0.313720703125
▁impact 1.8759765625
▁of 0.130126953125
▁this 3.916015625
▁disease 4.70703125
▁on 0.1807861328125
▁clin 5.5390625
ical 0.005489349365234375
▁out 0.1719970703125
comes 0.000232696533203125
, 0.21337890625
▁and 0.039093017578125
▁expl 2.091796875
ores 0.00016939640045166016
▁the 1.064453125
▁role 1.681640625
▁of 0.042236328125
▁middle 14.546875
▁mole 1.0244140625
cules 0.345703125
▁in 0.429931640625
▁the 1.1396484375
▁development 1.6201171875
▁of 0.2457275390625
▁path 7.16796875
ology 2.353515625
. 0.44677734375
▁Furthermore 3.865234375
, 0.0015153884887695312
▁the 0.374755859375
▁article 0.185302734375
▁provides 1.50390625
▁ins 2.126953125
ights 0.0002467632293701172
▁into 0.1634521484375
▁the 0.56689453125
▁latest 3.908203125
▁break 5.45703125
through 0.0003871917724609375
s 0.014678955078125
▁and 2.681640625
▁research 2.4921875
▁in 1.123046875
▁d 5.78125
ial 0.005977630615234375
ysis 0.021148681640625
▁that 4.140625
▁aim 2.69921875
▁to 0.0097503662109375
▁stabil 10.59375
ize 0.01519775390625
▁this 4.51171875
▁condition 1.00390625
. 0.41796875
▁This 2.837890625
▁ess 4.015625
ay 0.001094818115234375
▁will 1.0078125
▁analyze 2.35546875
▁the 0.61669921875
▁key 3.046875
▁points 0.59912109375
▁presented 2.2265625
▁in 0.08868408203125
▁the 0.15771484375
▁article 0.0765380859375
▁while 4.09375
▁offering 3.349609375
▁additional 1.439453125
▁pers 1.419921875
pect 5.233287811279297e-05
ives 3.5762786865234375e-06
▁on 0.703125
▁the 0.67578125
▁topic 0.94873046875
. 0.359375
<0x0A> 0.1458740234375
C 3.921875
aus 0.343017578125
es 0.003437042236328125
▁of 0.2255859375
▁Chron 0.09259033203125
ic 0.0002040863037109375
▁In 0.00482940673828125
fl 0.00021946430206298828
amm 0.00377655029296875
ation 0.0003020763397216797
▁in 0.309326171875
▁Ind 2.87109375
ividual 0.00010919570922851562
s 0.0008420944213867188
▁with 0.093505859375
▁E 0.19140625
SR 0.0007510185241699219
D 0.00025463104248046875
: 0.60693359375
<0x0A> 0.36181640625
The 0.810546875
▁article 0.38232421875
▁highlight 1.5654296875
s 0.0059356689453125
▁several 1.69921875
▁causes 1.884765625
▁of 0.07708740234375
▁chron 0.039337158203125
ic 6.568431854248047e-05
▁infl 0.0018939971923828125
amm 0.0047607421875
ation 8.499622344970703e-05
▁in 0.09234619140625
▁E 3.685546875
SR 0.0002090930938720703
D 3.1113624572753906e-05
, 1.0556640625
▁r 6.69921875
anging 0.00095367431640625
▁from 0.0006361007690429688
▁d 4.140625
ial 0.01357269287109375
ysis 0.032012939453125
- 1.1103515625
related 0.3427734375
▁factors 0.9814453125
▁to 0.52197265625
▁com 2.591796875
orb 0.0001252889633178711
id 0.0005950927734375
ities 0.138916015625
. 0.68603515625
▁D 1.39453125
ial 0.00974273681640625
ysis 0.01459503173828125
- 0.55615234375
related 0.056793212890625
▁factors 0.1907958984375
▁such 1.2021484375
▁as 0.0010194778442382812
▁memb 4.17578125
rane 0.1580810546875
▁bio 4.58203125
in 5.74609375
compat 0.024627685546875
ibility 0.042694091796875
, 0.471923828125
▁end 6.10546875
ot 0.1318359375
ox 0.0021076202392578125
in 1.0947265625
▁expos 0.96826171875
ure 0.00118255615234375
, 0.09027099609375
▁and 0.37109375
▁ox 2.552734375
id 0.005580902099609375
ative 0.04443359375
▁stress 0.03326416015625
▁contribute 2.51953125
▁to 0.23095703125
▁the 1.205078125
▁activation 5.39453125
▁of 0.0296478271484375
▁infl 1.0703125
am 0.038238525390625
mat 2.86102294921875e-05
ory 2.288818359375e-05
▁path 0.3310546875
ways 0.0031299591064453125
. 0.99658203125
▁Additionally 2.328125
, 0.0002903938293457031
▁com 0.5517578125
orb 0.00024700164794921875
id 0.0002498626708984375
ities 0.04425048828125
▁like 2.205078125
▁hy 3.865234375
pert 0.07379150390625
ension 0.0012769699096679688
, 0.2841796875
▁di 0.391357421875
ab 0.00017845630645751953
etes 0.0006351470947265625
, 0.64794921875
▁and 0.43115234375
▁long 10.5703125
- 0.0196380615234375
term 0.0859375
▁in 3.595703125
fe 0.2802734375
ctions 3.2186508178710938e-06
▁play 4.27734375
▁a 0.1766357421875
▁role 1.48828125
▁in 0.02276611328125
▁indu 4.0625
cing 0.00010728836059570312
▁chron 0.763671875
ic 0.0005884170532226562
▁infl 0.0139007568359375
amm 0.051788330078125
ation 8.285045623779297e-05
▁in 1.197265625
▁E 0.9462890625
SR 0.00014197826385498047
D 0.00011360645294189453
▁patients 0.7900390625
. 0.2119140625
▁Under 4.83203125
standing 0.025970458984375
▁these 0.62646484375
▁causes 0.6611328125
▁is 0.47021484375
▁cru 1.244140625
cial 2.09808349609375e-05
▁for 0.8984375
▁man 3.326171875
aging 0.00020933151245117188
▁and 2.349609375
▁developing 7.14453125
▁strateg 1.6083984375
ies 0.00015592575073242188
▁to 0.2000732421875
▁prevent 1.8466796875
▁and 2.359375
▁mit 3.08203125
ig 6.079673767089844e-06
ate 0.0001690387725830078
▁chron 1.115234375
ic 0.00022995471954345703
▁infl 0.0028285980224609375
amm 0.0399169921875
ation 9.691715240478516e-05
▁in 0.2357177734375
▁E 1.107421875
SR 0.0002231597900390625
D 2.86102294921875e-05
. 0.765625
<0x0A> 0.04473876953125
Imp 0.31103515625
act 0.001720428466796875
▁of 0.228759765625
▁Chron 0.03741455078125
ic 2.5153160095214844e-05
▁In 0.0008640289306640625
fl 8.26120376586914e-05
amm 0.0009937286376953125
ation 6.949901580810547e-05
▁on 0.044708251953125
▁C 0.01445770263671875
lin 2.5391578674316406e-05
ical 0.0003662109375
▁Out 0.0019626617431640625
comes 0.0022296905517578125
: 0.07928466796875
<0x0A> 0.006927490234375
Chr 0.85107421875
onic 0.00015032291412353516
▁infl 0.0041656494140625
amm 0.0026531219482421875
ation 4.017353057861328e-05
▁has 1.2294921875
▁a 0.6220703125
▁significant 0.58349609375
▁impact 0.08953857421875
▁on 0.00032591819763183594
▁clin 0.17236328125
ical 0.00016486644744873047
▁out 0.0006556510925292969
comes 9.059906005859375e-06
▁in 0.18115234375
▁individuals 0.9462890625
▁with 0.00664520263671875
▁E 0.0023708343505859375
SR 4.315376281738281e-05
D 8.106231689453125e-06
. 0.31103515625
▁The 1.15234375
▁article 0.2203369140625
▁emphas 1.9814453125
izes 0.0010814666748046875
▁that 0.6162109375
▁chron 0.98388671875
ic 0.0019063949584960938
▁infl 0.01203155517578125
amm 0.017974853515625
ation 3.528594970703125e-05
▁serves 7.66796875
▁as 0.01425933837890625
▁an 1.7060546875
▁independent 0.59228515625
▁risk 0.69189453125
▁factor 0.011688232421875
▁for 0.048919677734375
▁card 1.5771484375
i 0.004364013671875
ov 0.0005288124084472656
asc 3.552436828613281e-05
ular 2.0265579223632812e-06
▁dise 3.04296875
ases 0.00018095970153808594
, 0.498779296875
▁mort 2.2578125
ality 0.0013065338134765625
, 0.034881591796875
▁and 0.138671875
▁hospital 1.8046875
ization 0.6064453125
. 0.77587890625
▁It 2.3046875
▁cont 5.23828125
ributes 0.038665771484375
▁to 0.03759765625
▁the 0.82666015625
▁path 3.81640625
ogen 0.25390625
esis 0.003948211669921875
▁of 0.0299224853515625
▁a 1.806640625
ther 0.08880615234375
os 0.0278778076171875
cl 0.232421875
eros 1.430511474609375e-06
is 2.7298927307128906e-05
, 0.464111328125
▁ar 4.453125
ter 0.0653076171875
ial 0.2509765625
▁st 0.61572265625
iff 0.0181427001953125
ness 0.18505859375
, 0.00970458984375
▁and 0.21533203125
▁acceler 5.69921875
ated 0.289794921875
▁card 3.134765625
i 0.339599609375
ov 0.0049896240234375
asc 7.641315460205078e-05
ular 0.0001722574234008789
▁events 3.14453125
. 0.69677734375
▁Moreover 2.662109375
, 0.00013554096221923828
▁chron 0.5126953125
ic 0.00016129016876220703
▁infl 0.004669189453125
amm 0.0048828125
ation 4.267692565917969e-05
▁dis 5.42578125
rupt 0.0106353759765625
s 0.00011610984802246094
▁the 0.55517578125
▁balance 1.9599609375
▁of 0.7744140625
▁imm 2.904296875
une 0.24072265625
▁responses 1.6005859375
▁and 1.0888671875
▁ex 4.73828125
ac 0.26806640625
erb 0.00021398067474365234
ates 0.0010833740234375
▁kid 4.7109375
ney 0.000331878662109375
▁damage 1.3291015625
. 0.8232421875
▁These 3.076171875
▁out 2.755859375
comes 0.00017392635345458984
▁highlight 1.03125
▁the 0.00852203369140625
▁ur 2.802734375
gent 0.28515625
▁need 0.019500732421875
▁for 0.3310546875
▁inter 1.8173828125
vent 0.06280517578125
ions 0.0361328125
▁target 3.1484375
ing 0.108154296875
▁chron 0.4052734375
ic 5.793571472167969e-05
▁infl 0.0018854141235351562
amm 0.00965118408203125
ation 4.208087921142578e-05
▁in 0.364990234375
▁E 0.35009765625
SR 0.00010514259338378906
D 1.2993812561035156e-05
▁patients 0.9970703125
▁to 1.5439453125
▁improve 0.25
▁their 0.92041015625
▁clin 0.89697265625
ical 0.00020563602447509766
▁pro 4.18359375
gn 0.002925872802734375
osis 0.1671142578125
. 0.0914306640625
<0x0A> 0.01166534423828125
Role 0.2403564453125
▁of 0.00119781494140625
▁Middle 0.038604736328125
▁M 0.00930023193359375
ole 8.344650268554688e-05
cules 0.006351470947265625
▁in 0.021820068359375
▁Path 1.201171875
ology 0.358642578125
: 0.12060546875
<0x0A> 0.006046295166015625
Middle 1.76171875
▁mole 0.0257415771484375
cules 0.00665283203125
▁play 1.697265625
▁a 0.2166748046875
▁cru 0.91650390625
cial 3.933906555175781e-06
▁role 0.0019235610961914062
▁in 0.0002837181091308594
▁the 0.56201171875
▁development 0.55810546875
▁of 0.1199951171875
▁path 0.87890625
ology 0.040283203125
▁associated 2.8671875
▁with 0.0003476142883300781
▁E 2.3515625
SR 0.00018990039825439453
D 1.990795135498047e-05
▁and 1.1748046875
▁chron 2.59765625
ic 4.1365623474121094e-05
▁infl 0.03997802734375
amm 0.004024505615234375
ation 5.733966827392578e-05
. 0.01580810546875
▁As 5.13671875
▁the 2.66796875
▁article 0.056365966796875
▁suggests 2.673828125
, 0.00067138671875
▁middle 1.1318359375
▁mole 0.011077880859375
cules 0.0102996826171875
, 3.103515625
▁including 1.7646484375
▁ 6.72265625
β 1.888671875
2 0.43310546875
- 0.08526611328125
m 0.8779296875
icro 0.00809478759765625
glob 0.010223388671875
ul 0.0004494190216064453
in 0.031951904296875
, 0.5087890625
▁par 3.041015625
ath 0.0212249755859375
y 0.0193634033203125
roid 0.00018489360809326172
▁h 0.004913330078125
orm 9.5367431640625e-07
one 0.005580902099609375
▁fragments 9.53125
, 0.055755615234375
▁and 0.352783203125
▁advanced 4.10546875
▁g 0.04681396484375
ly 8.308887481689453e-05
cation 0.0055389404296875
▁end 0.00943756103515625
▁products 0.1810302734375
, 0.233642578125
▁accum 3.640625
ulate 0.0011777877807617188
▁due 3.673828125
▁to 0.0001933574676513672
▁decre 4.49609375
ased 0.003437042236328125
▁ren 1.4521484375
al 0.0002281665802001953
▁clear 0.401611328125
ance 0.0025005340576171875
▁in 1.8095703125
▁E 0.67919921875
SR 6.99758529663086e-05
D 1.5139579772949219e-05
▁patients 0.8974609375
. 0.180908203125
▁These 0.5673828125
▁mole 0.366455078125
cules 0.0021457672119140625
, 4.79296875
▁especially 4.1328125
▁ 0.25634765625
β 0.0012025833129882812
2 0.0124359130859375
- 0.0093231201171875
m 0.01080322265625
icro 0.0001233816146850586
glob 0.00119781494140625
ul 9.000301361083984e-05
in 0.0018167495727539062
, 0.06512451171875
▁have 1.7158203125
▁pro 2.388671875
- 0.529296875
infl 0.01605224609375
am 6.580352783203125e-05
mat 2.3365020751953125e-05
ory 9.298324584960938e-06
▁properties 1.1494140625
▁and 0.5693359375
▁contribute 1.1298828125
▁to 0.03009033203125
▁the 0.7236328125
▁activation 2.396484375
▁of 0.0288543701171875
▁infl 0.771484375
am 0.022674560546875
mat 1.0728836059570312e-06
ory 1.049041748046875e-05
▁path 0.1490478515625
ways 0.001354217529296875
, 2.060546875
▁eventually 4.875
▁leading 0.401123046875
▁to 0.0007176399230957031
▁t 2.29296875
issue 0.0002608299255371094
▁damage 0.2142333984375
▁and 0.66943359375
▁system 4.29296875
ic 0.004810333251953125
▁infl 0.5869140625
amm 0.046630859375
ation 9.715557098388672e-05
. 0.0224609375
▁The 2.322265625
▁identification 3.041015625
▁and 0.92041015625
▁target 2.57421875
ing 0.1009521484375
▁of 0.0012836456298828125
▁middle 1.2109375
▁mole 0.0038166046142578125
cules 0.0111083984375
▁hold 3.06640625
▁promise 2.10546875
▁as 2.49609375
▁an 3.046875
▁effective 0.6591796875
▁approach 1.498046875
▁to 0.5166015625
▁reducing 3.228515625
▁chron 1.0927734375
ic 0.00021827220916748047
▁infl 0.0027179718017578125
amm 0.01605224609375
ation 1.990795135498047e-05
▁in 0.383056640625
▁E 0.1295166015625
SR 0.00018012523651123047
D 2.9921531677246094e-05
▁patients 0.437255859375
. 0.106201171875
<0x0A> 0.010772705078125
Lat 1.330078125
est 3.933906555175781e-05
▁Break 0.1461181640625
through 5.614757537841797e-05
s 0.0027713775634765625
▁and 0.2430419921875
▁Research 0.0142669677734375
▁in 0.1124267578125
▁D 0.009429931640625
ial 2.7418136596679688e-05
ysis 0.0001684427261352539
: 0.06927490234375
<0x0A> 0.0021877288818359375
Rec 2.78515625
ent 0.02227783203125
▁adv 1.123046875
anc 0.576171875
ements 6.9141387939453125e-06
▁in 0.202880859375
▁d 0.09765625
ial 4.76837158203125e-06
ysis 0.00079345703125
▁aim 3.064453125
▁to 0.0170135498046875
▁stabil 0.5439453125
ize 0.00024020671844482422
▁the 1.626953125
▁condition 1.732421875
▁of 0.224365234375
▁individuals 0.87451171875
▁with 0.027740478515625
▁E 0.07403564453125
SR 7.56978988647461e-05
D 6.318092346191406e-06
▁and 0.80908203125
▁mit 2.9140625
ig 3.814697265625e-06
ate 3.0040740966796875e-05
▁chron 0.68798828125
ic 1.9788742065429688e-05
▁infl 0.0006070137023925781
amm 0.006031036376953125
ation 2.944469451904297e-05
. 0.0465087890625
▁The 0.80517578125
▁article 0.07818603515625
▁mentions 2.8125
▁emer 5.3046875
ging 0.00618743896484375
▁d 2.8125
ial 0.00011324882507324219
ysis 0.0712890625
▁techniques 1.9150390625
, 0.87841796875
▁such 0.62841796875
▁as 0.0001634359359741211
▁online 4.41796875
▁hem 0.31201171875
odia 0.07989501953125
fil 0.006908416748046875
tr 0.0014371871948242188
ation 0.0001513957977294922
▁( 2.3515625
H 1.240234375
DF 0.004497528076171875
) 0.78076171875
▁and 0.0477294921875
▁high 2.669921875
▁cut 5.37109375
- 0.361572265625
off 0.0108642578125
▁( 1.7314453125
H 0.0216827392578125
CO 0.00986480712890625
) 0.04754638671875
▁memb 1.3271484375
ran 0.245361328125
es 0.0001786947250366211
, 0.0634765625
▁which 0.94580078125
▁have 1.7421875
▁shown 1.24609375
▁prom 0.6591796875
ising 3.8504600524902344e-05
▁results 0.1544189453125
▁in 0.02471923828125
▁reducing 0.274169921875
▁infl 0.6123046875
amm 0.5234375
ation 0.0002951622009277344
▁and 0.765625
▁impro 0.60205078125
ving 2.384185791015625e-05
▁patient 1.9130859375
▁out 0.0628662109375
comes 8.702278137207031e-06
. 0.01177978515625
▁The 3.69140625
▁combination 5.14453125
▁of 0.0242767333984375
▁these 1.6806640625
▁advanced 4.546875
▁techniques 1.033203125
▁with 0.18310546875
▁optimized 4.703125
▁d 0.9912109375
ial 5.5670738220214844e-05
ys 3.439453125
ate 0.042633056640625
▁composition 1.6806640625
▁and 0.921875
▁individual 5.51171875
ized 0.054443359375
▁treatment 2.02734375
▁plans 1.52734375
▁further 4.8125
▁enh 0.76953125
ances 0.134765625
▁their 1.0458984375
▁effect 0.99169921875
iveness 0.004222869873046875
. 0.67529296875
▁Furthermore 3.220703125
, 5.125999450683594e-05
▁research 2.025390625
ers 1.7724609375
▁are 0.1563720703125
▁investig 1.83203125
ating 5.125999450683594e-06
▁novel 2.271484375
▁th 2.69140625
era 0.0008134841918945312
pe 4.649162292480469e-06
ut 9.655952453613281e-06
ic 0.1676025390625
▁targets 2.921875
, 0.77685546875
▁including 0.7607421875
▁cy 3.041015625
tok 0.026885986328125
ines 0.2161865234375
▁and 0.8720703125
▁infl 2.52734375
am 0.24609375
mat 1.4662742614746094e-05
ory 2.5033950805664062e-05
▁signal 2.923828125
ing 0.011199951171875
▁path 0.08770751953125
ways 0.0007429122924804688
, 0.025299072265625
▁to 0.456298828125
▁develop 0.6962890625
▁anti 5.67578125
- 0.00037741661071777344
infl 0.0021800994873046875
am 0.0007343292236328125
mat 1.0251998901367188e-05
ory 1.1920928955078125e-06
▁dru 2.306640625
gs 3.2186508178710938e-06
▁specific 4.2421875
▁to 0.093505859375
▁E 0.27099609375
SR 0.00013339519500732422
D 7.510185241699219e-06
▁patients 0.467041015625
. 0.046783447265625
<0x0A> 0.435791015625
Con 1.6845703125
clusion 0.1744384765625
: 0.124267578125
<0x0A> 6.2734375
In 1.162109375
▁conclusion 0.133544921875
, 0.00021731853485107422
▁chron 0.26513671875
ic 2.6345252990722656e-05
▁infl 0.00033926963806152344
amm 0.0010232925415039062
ation 1.0609626770019531e-05
▁is 0.5390625
▁a 0.042236328125
▁complex 4.66796875
▁issue 3.51171875
▁in 1.251953125
▁E 1.7587890625
SR 4.982948303222656e-05
D 5.841255187988281e-06
▁patients 0.39453125
▁under 1.080078125
going 0.0013837814331054688
▁d 0.00708770751953125
ial 3.4570693969726562e-06
ysis 6.520748138427734e-05
. 0.58837890625
▁Under 1.658203125
standing 0.0020999908447265625
▁the 0.356689453125
▁leading 2.580078125
▁causes 0.006076812744140625
▁of 1.6025390625
▁chron 0.376220703125
ic 6.496906280517578e-05
▁infl 0.0003199577331542969
amm 0.0003306865692138672
ation 5.1856040954589844e-05
, 0.328369140625
▁its 1.00390625
▁impact 0.043243408203125
▁on 0.0019989013671875
▁clin 0.006122589111328125
ical 3.2901763916015625e-05
▁out 0.00794219970703125
comes 2.5033950805664062e-06
, 0.0052032470703125
▁and 0.034881591796875
▁the 0.05267333984375
▁role 0.0252685546875
▁of 0.0023670196533203125
▁middle 0.00666046142578125
▁mole 0.0010833740234375
cules 0.00045752525329589844
▁in 0.078857421875
▁the 2.111328125
▁development 0.25341796875
▁of 0.0009546279907226562
▁path 0.037078857421875
ology 0.004581451416015625
▁is 0.1910400390625
▁vital 3.361328125
▁for 0.4228515625
▁effective 2.26953125
▁management 0.285888671875
▁and 0.88427734375
▁prevent 2.232421875
ion 0.0199737548828125
. 0.81787109375
▁Fort 5.20703125
un 0.0005087852478027344
ately 5.7220458984375e-05
, 0.00015854835510253906
▁recent 0.55810546875
▁break 1.333984375
through 8.225440979003906e-06
s 0.0001513957977294922
▁and 0.33740234375
▁on 5.84765625
going 0.001125335693359375
▁research 0.00418853759765625
▁in 0.242431640625
▁d 0.063720703125
ial 1.6808509826660156e-05
ysis 0.001251220703125
▁offer 1.0283203125
▁hope 0.88037109375
▁for 0.093505859375
▁stabil 0.93603515625
izing 0.00792694091796875
▁the 0.90087890625
▁condition 0.03399658203125
▁and 1.138671875
▁alle 4.1171875
vi 2.1696090698242188e-05
ating 0.00022614002227783203
▁chron 1.0380859375
ic 2.3603439331054688e-05
▁infl 0.000579833984375
amm 0.006320953369140625
ation 1.3828277587890625e-05
▁through 8.390625
▁advanced 1.4501953125
▁techniques 0.4189453125
▁and 0.2281494140625
▁target 0.86669921875
ed 0.01146697998046875
▁ther 1.30859375
ap 0.04718017578125
ies 2.9802322387695312e-05
. 0.01331329345703125
▁By 2.4765625
▁address 2.095703125
ing 1.6570091247558594e-05
▁chron 2.349609375
ic 2.6464462280273438e-05
▁infl 0.0006399154663085938
amm 0.0012531280517578125
ation 1.8596649169921875e-05
▁in 1.0361328125
▁E 0.12493896484375
SR 0.00012814998626708984
D 8.225440979003906e-06
▁patients 0.11102294921875
, 0.08099365234375
▁health 2.4140625
care 0.0384521484375
▁profession 0.6142578125
als 8.344650268554688e-07
▁can 0.11688232421875
▁significantly 2.716796875
▁improve 0.039398193359375
▁the 2.64453125
▁quality 0.459228515625
▁of 0.0014238357543945312
▁life 0.016143798828125
▁and 0.53662109375
▁pro 1.8076171875
gn 0.00011110305786132812
osis 0.0036373138427734375
▁for 1.7333984375
▁these 0.362548828125
▁individuals 0.09912109375
. 0.046112060546875
